Recent Examples on the WebAt the same time, a conflux of issues presents challenges: health insurers and politicians have stepped up pressure on prices; R&D is often expensive and unsuccessful; and competition from low-cost generics remains a threat. Peter Loftus, WSJ, 7 Sep. 2017